In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study
- 27 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 48 (2), 414-420
- https://doi.org/10.1007/s00259-020-04878-9
Abstract
Purpose Alteration in mitochondrial membrane potential (ΔΨm) is an important feature of many pathologic processes, including heart failure, cardiotoxicity, ventricular arrhythmia, and myocardial hypertrophy. We present the first in vivo, non-invasive, assessment of regional ΔΨm in the myocardium of normal human subjects. Methods Thirteen healthy subjects were imaged using [18F]-triphenylphosphonium ([18F]TPP+) on a PET/MR scanner. The imaging protocol consisted of a bolus injection of 300 MBq followed by a 120-min infusion of 0.6 MBq/min. A 60 min, dynamic PET acquisition was started 1 h after bolus injection. The extracellular space fraction (fECS) was simultaneously measured using MR T1-mapping images acquired at baseline and 15 min after gadolinium injection with correction for the subject’s hematocrit level. Serial venous blood samples were obtained to calculate the plasma tracer concentration. The tissue membrane potential (ΔΨT), a proxy of ΔΨm, was calculated from the myocardial tracer concentration at secular equilibrium, blood concentration, and fECS measurements using a model based on the Nernst equation. Results In 13 healthy subjects, average tissue membrane potential (ΔΨT), representing the sum of cellular membrane potential (ΔΨc) and ΔΨm, was − 160.7 ± 3.7 mV, in excellent agreement with previous in vitro assessment. Conclusion In vivo quantification of the mitochondrial function has the potential to provide new diagnostic and prognostic information for several cardiac diseases as well as allowing therapy monitoring. This feasibility study lays the foundation for further investigations to assess these potential roles. Clinical trial identifier: NCT03265431Keywords
Funding Information
- National Institutes of Health (P41EB022544, R01HL137230, T32EB013180)
This publication has 29 references indexed in Scilit:
- Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium‐induced de‐ and hyperpolarization of neuronal mitochondriaJournal Of Physiology-London, 2012
- 4-[18F]-Tetraphenylphosphonium as a PET Tracer for Myocardial Mitochondrial Membrane PotentialJACC: Cardiovascular Imaging, 2012
- Measuring mitochondrial function in intact cardiac myocytesJournal of Molecular and Cellular Cardiology, 2012
- Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for TherapyThe American Journal of Cardiology, 2010
- The Mitochondrial Pathway of Anesthetic Isoflurane-induced ApoptosisOnline Journal of Public Health Informatics, 2010
- Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen speciesCardiovascular Research, 2008
- Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heartMagnetic Resonance in Medicine, 2004
- Membrane potential and surface potential in mitochondria: Uptake and binding of lipophilic cationsThe Journal of Membrane Biology, 1984
- Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady stateThe Journal of Membrane Biology, 1979